Implications Of External Price Referencing of Pharmaceuticals in Middle East Countries
Value Health
.
2014 Nov;17(7):A409.
doi: 10.1016/j.jval.2014.08.960.
Epub 2014 Oct 26.
Authors
Z Kalo
1
,
I Alabbadi
2
,
Ahdab O G Al
3
,
D Al-Badriyeh
4
,
M Alowayesh
5
,
A H Al-Saggabi
6
,
M Elmahdawy
7
,
V L Tanzi
8
,
H Alsultan
9
,
K Akhras
10
,
P Kanavos
11
Affiliations
1
Eötvös Loránd University (ELTE), Budapest, Hungary.
2
University of Jordan, Amman, Jordan.
3
Ministry of Health, Abu Dhabi, United Arab Emirates.
4
College of Pharmacy, Qatar University, Doha, Qatar.
5
Kuwait University, Yarmook, Kuwait.
6
Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
7
Ministry of Health, Cairo, Egypt.
8
American University of Beirut, Beirut, Lebanon.
9
Dasman Diabetes Institute, Yarmook, Kuwait.
10
Novartis, Dubai, United Arab Emirates.
11
London School of Economics and Political Science, London, UK.
PMID:
27201002
DOI:
10.1016/j.jval.2014.08.960
No abstract available